Ensuring Data Integrity in Healthcare

In the medical field, incorrect or tampered data does not merely result in a statistical discrepancy—it can endanger patients, trigger a costly product recall, or expose a manufacturer to severe regulatory penalties. The FDA, EMA, and ISO 13485 standards place data integrity at the heart of their requirements. Yet, between manual data entry, disparate systems, and the pressure of production schedules, maintaining a reliable end-to-end data chain remains a daily challenge for quality teams.

What is meant by data integrity in a medical context?

Data integrity refers to the assurance that each piece of data is complete, consistent, accurate, and traceable throughout its life cycle—from initial measurement through archiving. In the pharmaceutical and medical device industries, this concept is often referred to by the acronym ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, and Available). Each letter represents a criterion that FDA or ANSM inspectors are likely to verify during an inspection.

In practical terms, this covers everything from how an operator enters a measurement result to how statistical process control (SPC) software— Statistical Process Control) stores and time-stamps the records. A simple copy-and-paste without traceability or an undocumented manual correction can constitute a major regulatory violation.

The Main Sources of Risk to Data Integrity

Manual data entry and paper

Manual data collection remains common on medical production lines, particularly in small and medium-sized facilities. This method of data collection poses several risks: transcription errors, missing data, untraceable changes, and difficulties in reconstructing the history during an audit. A study by the Parenteral Drug Association estimated that more than 80 % of data integrity findings during inspections involved procedures using paper or unsecured files.

Unvalidated systems and spreadsheet files

Excel-style spreadsheets are ubiquitous, but they have structural shortcomings: no user-based access controls, formulas that can be modified without an audit trail, and no electronic signatures that comply with regulations 21 CFR Part 11 (the FDA’s reference document governing electronic records). The use of files shared on a common network increases these risks.

Transfers Between Systems

Every interface between measurement equipment, ERP systems, LIMS, or SPC software represents a potential point of data loss or corruption. A formatting issue, a connection timeout, or a field-mapping error can introduce invisible inconsistencies if no automatic verification mechanism is in place.

Best Practices for Securing the Data Chain

Automate withholding at the source. Connecting measurement instruments directly to data processing software—via standardized protocols such as OPC-UA or serial interfaces—eliminates the need for manual data entry and ensures that the recorded value is the one actually produced by the instrument.

Establish a robust audit trail. Any IT system used in a regulated environment must automatically log who modified what, when, and why. The operator must not be able to delete a record without leaving a trace. SPC software that complies with 21 CFR Part 11 natively includes this functionality.

Implement strict access rights management. User profiles must be differentiated based on roles: a production line operator does not have the same permissions as a quality manager or a system administrator. An electronic signature with a username and password must be required for any critical approval.

Define and validate data transfer procedures. Every data flow between systems must be documented, tested, and validated (IQ/OQ/PQ qualification — Installation, Operational, and Performance Qualification). Automatic consistency checks—such as verifying the expected number of lines or valid value ranges—enable the rapid detection of transfer anomalies.

Provide regular training for the teams. Technology alone is not enough. Operators and quality engineers must understand why these requirements exist and what the consequences are of a deviation, whether intentional or not.

The Role of SPC Tools in Continuous Monitoring

Properly configured SPC software does more than just calculate capability indices (Cp, Cpk) or plot control charts. In a medical setting, it serves as an active link in the chain of integrity: it time-stamps each data point, associates each record with an identified user, generates alerts in the event of deviations, and produces auditable reports. Some tools also allow you to configure rules for automatically detecting suspicious values—for example, repeated identical measurements that could indicate fictitious data entry.

Ensuring data integrity in the healthcare sector is not a one-time project: it is an ongoing discipline that combines organizational rigor, appropriate technological choices, and a culture of quality shared by all stakeholders in the production line. Manufacturers who embrace it as an operational reflex—rather than as a regulatory constraint they are forced to endure—are less likely to face non-compliance issues and are better prepared for audits.